Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine materials were contaminated, the lawsuit said.
Advertisement
Via New York Times
Read original article
Comments (0)
Add a Comment
No comments yet